Active Ingredient History
Organization | Org Type | FDA approvals | Clinical Trials involvement | Org ID | Force Sort |
---|
Organization | Org Type | FDA approvals | Clinical Trials involvement | Org ID | Force Sort |
---|
Anemia, Aplastic (Phase 2)
Anemia, Sickle Cell (Phase 2)
Bone Marrow Failure Disorders (Phase 2)
Granulomatous Disease, Chronic (Early Phase 1)
Hematologic Neoplasms (Phase 2)
Hemoglobins (Phase 2)
Hodgkin Disease (Phase 3)
Leukemia, Myeloid, Acute (Phase 3)
Lymphoma, Non-Hodgkin (Phase 3)
Metabolic Diseases (Phase 2)
Myelodysplastic Syndromes (Phase 3)
Myeloproliferative Disorders (Phase 3)
Neoplasms (Phase 4)
Neuroblastoma (Early Phase 1)
Primary Immunodeficiency Diseases (Phase 2)
Trial | Phase | Start Date | Organizations | Indications |
---|
Feedback
Data collection and curation is an ongoing process for CDEK - if you notice any information here to be missing or incorrect, please let us know! When possible, please include a source URL (we verify all data prior to inclusion).
Report issue